hydronidone,
N-(4-hydroxyphenyl)-5-methyl-2-pyridone,
1-(4-Hydroxyphenyl)-5-methylpyridin-2(1H)-one,
851518-71-3,
F-351,
UNII-RXQ128313W,
RXQ128313W,
N-(4-HYDROXYPHENYL)-5-METHYL-2-1H-PYRIDONE,
N-(4-Hydroxyphenyl)-5-methyl-2-pyridone,
F 351,
1-(4-hydroxyphenyl)-5-methyl-1H-pyridine-2-one,
Hydronidone,
1-(4-Hydroxyphenyl)-5-methyl-2(1H)-pyridinone,
SCHEMBL143564,
C12H10BNO2,
CTK7J9389,
DTXSID40459058,
0698AF,
3175AC,
ANW-67640,
ZINC21981322,
AKOS016006473,
SB18945,
AJ-78844,
AX8237170,
TC-156385,
FT-0669968,
Liver fibrosis, Shanghai,
Liver cirrhosis, Shanghai,
D00AKV,
9H-Carbazol-3ylboronic acid,
C12H11NO2,
CID11217901,
Liver fibrosis therapy, Shanghai Genomics,
Liver fibrosis, Gene Networks International,
Liver cirrhosis, Gene Networks International,
1-(4-hydroxyphenyl)-5-methyl-pyridin-2-one,
851524-97-5,